Cargando…
Valproic acid attenuates cellular senescence in diabetic kidney disease through the inhibition of complement C5a receptors
Despite increasing knowledge about the factors involved in the progression of diabetic complications, diabetic kidney disease (DKD) continues to be a major health burden. Current therapies only slow but do not prevent the progression of DKD. Thus, there is an urgent need to develop novel therapy to...
Autores principales: | Coughlan, Melinda T., Ziemann, Mark, Laskowski, Adrienne, Woodruff, Trent M., Tan, Sih Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700697/ https://www.ncbi.nlm.nih.gov/pubmed/36434087 http://dx.doi.org/10.1038/s41598-022-24851-w |
Ejemplares similares
-
Therapeutic Potential of Targeting Complement C5a Receptors in Diabetic Kidney Disease
por: Trambas, Inez A., et al.
Publicado: (2023) -
The Complement Pathway: New Insights into Immunometabolic Signaling in Diabetic Kidney Disease
por: Tan, Sih Min, et al.
Publicado: (2022) -
Targeting Methylglyoxal in Diabetic Kidney Disease Using the Mitochondria-Targeted Compound MitoGamide
por: Tan, Sih Min, et al.
Publicado: (2021) -
Valproic acid influences the expression of genes implicated with hyperglycaemia-induced complement and coagulation pathways
por: Felisbino, Marina Barreto, et al.
Publicado: (2021) -
Sestrin2 Attenuates Cellular Senescence by Inhibiting NADPH Oxidase 4 Expression
por: Hwang, Chae Young, et al.
Publicado: (2020)